OpenBilldrug price receipt

NADAC week of 2026-10-14

RAMELTEON 8 MG TABLET

For 30 tablets

Pharmacies pay

$19.79 filed

30 × $0.65983 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$90.91 filed

30 × $3.0302 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.6× estimated

Medicare paid 4.6× what pharmacies pay.

Part D averages every strength and form sold under “Ramelteon” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$27.76 estimated

$19.79 + $2.97 (15%) + $5.00 fee per fill = $27.76

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RAMELTEON 8 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ramelteon.

FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Upsher-Smith Laboratories, LLC and Major Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Melatonin Receptor Agonist.

The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 21 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $19.79 for 30 tablets (30 × $0.65983 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
Xiromed, LLC3$0.65983 per EA filed
Actavis Pharma, Inc.2$0.65983 per EA filed
Aurobindo Pharma Limited2$0.65983 per EA filed
Kanchan Healthcare Inc2$0.65983 per EA filed
Micro Labs Limited2$0.65983 per EA filed
TruPharma, LLC2$0.65983 per EA filed
Upsher-Smith Laboratories, LLC2$0.65983 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.65983 per EA filed
American Health Packaging1$0.65983 per EA filed
AvPAK1$0.65983 per EA filed
Granules Pharmaceuticals Inc.1$0.65983 per EA filed
Major Pharmaceuticals1$0.65983 per EA filed
Not listed as a package in the FDA directory2$0.65983 per EA filed

When these prices took effect

All 23 NDCs, with labeler and price
  • 00591-2191-01 · Actavis Pharma, Inc. · $0.65983 per EA · eff. 2026-09-23 filed
  • 00591-2191-30 · Actavis Pharma, Inc. · $0.65983 per EA · eff. 2026-09-23 filed
  • 00832-1250-11 · Upsher-Smith Laboratories, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 00832-1250-30 · Upsher-Smith Laboratories, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 00904-7494-06 · Major Pharmaceuticals · $0.65983 per EA · eff. 2026-09-23 filed
  • 42571-0375-01 · Micro Labs Limited · $0.65983 per EA · eff. 2026-09-23 filed
  • 42571-0375-30 · Micro Labs Limited · $0.65983 per EA · eff. 2026-09-23 filed
  • 50268-0822-11 · not listed as a package in the FDA directory · $0.65983 per EA · eff. 2026-10-07 filed
  • 50268-0822-15 · AvPAK · $0.65983 per EA · eff. 2026-10-07 filed
  • 52817-0235-10 · TruPharma, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 52817-0235-30 · TruPharma, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 59651-0505-01 · Aurobindo Pharma Limited · $0.65983 per EA · eff. 2026-09-23 filed
  • 59651-0505-30 · Aurobindo Pharma Limited · $0.65983 per EA · eff. 2026-09-23 filed
  • 60687-0692-11 · not listed as a package in the FDA directory · $0.65983 per EA · eff. 2026-09-23 filed
  • 60687-0692-65 · American Health Packaging · $0.65983 per EA · eff. 2026-09-23 filed
  • 70010-0028-03 · Granules Pharmaceuticals Inc. · $0.65983 per EA · eff. 2026-09-23 filed
  • 70700-0272-05 · Xiromed, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 70700-0272-10 · Xiromed, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 70700-0272-30 · Xiromed, LLC · $0.65983 per EA · eff. 2026-09-23 filed
  • 70710-1344-01 · Zydus Pharmaceuticals USA Inc. · $0.65983 per EA · eff. 2026-09-23 filed
  • 70710-1344-03 · Zydus Pharmaceuticals USA Inc. · $0.65983 per EA · eff. 2026-09-23 filed
  • 85742-0023-22 · Kanchan Healthcare Inc · $0.65983 per EA · eff. 2026-09-30 filed
  • 85742-0023-23 · Kanchan Healthcare Inc · $0.65983 per EA · eff. 2026-09-30 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name ramelteon with RAMELTEON 8 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
RAMELTEON 8 MG TABLET this page
generic · tablet / tablet, film coated
$0.65983 per EA filed
eff. 2026-09-23 to 2026-10-07
$3.0302 per EA filed
Part D 2024 average
ROZEREM 8 MG TABLET
brand · tablet, film coated
$12.41691 per EA filed
eff. 2026-09-23
$11.47871 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $90.91 for 30 tablets, at an average of $3.0302 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ramelteon”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 221,935 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for RAMELTEON 8 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ramelteon / Ramelteon: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.